Kaiser Health News
MARCH 15, 2023
He said the new CDC guidance reflects “an extraordinary amount of input” from chronic pain patients and their doctors but doubts it will have much of an impact if the FDA and the Drug Enforcement Administration don’t change how they enforce federal laws.
Kaiser Health News
MARCH 15, 2023
He said the new CDC guidance reflects “an extraordinary amount of input” from chronic pain patients and their doctors but doubts it will have much of an impact if the FDA and the Drug Enforcement Administration don’t change how they enforce federal laws.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kaiser Health News
MARCH 15, 2023
La FDA aprueba nuevos medicamentos y sus reformulaciones, pero la orientación que brinda sobre cómo comenzar o removerle la droga a los pacientes podría instar a los médicos a hacerlo con precaución, dijo Kertesz.
Kaiser Health News
MARCH 15, 2023
La FDA aprueba nuevos medicamentos y sus reformulaciones, pero la orientación que brinda sobre cómo comenzar o removerle la droga a los pacientes podría instar a los médicos a hacerlo con precaución, dijo Kertesz.
Bill of Health
OCTOBER 5, 2023
Food and Drug Administration (FDA) has also begun to consider the regulation of clinical algorithms. In 2021, the FDA released an action plan for the regulation of artificial intelligence and machine learning in medicine, which included supporting the development of methods to evaluate algorithms for bias.
Hall Render
MAY 10, 2024
Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass.
Bill of Health
NOVEMBER 15, 2023
DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone.
Expert insights. Personalized for you.
88 
Let's personalize your content